Jill Marie Broadfoot
CIK: 0001305178
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (10 total)
- Jun 22, 2026TLPH
TALPHERA, INC.
Award(A)Direct5.1K shares- - Feb 4, 2026ATYR
aTYR PHARMA INC
Sale(S)Direct1.6K shares at avg. $0.98$2K - Feb 3, 2026ATYR
aTYR PHARMA INC
Exercise(M)Direct3.8K shares- - Jan 9, 2026ATYR
aTYR PHARMA INC
Award(A)DirectEmployee Stock Option (right to buy)
412.5K shares- - Jan 2, 2026CUE
Cue Biopharma, Inc.
Award(A)DirectStock Option (right to buy)
24.4K shares- - Oct 23, 2025TLPH
TALPHERA, INC.
Award(A)Direct4.3K shares- - Jun 4, 2025CUE
Cue Biopharma, Inc.
Award(A)DirectStock Option (right to buy)
48.8K shares- - Feb 4, 2025ATYR
aTYR PHARMA INC
Sale(S)Direct1.3K shares at avg. $3.78$5K - Feb 3, 2025ATYR
aTYR PHARMA INC
Exercise(M)Direct3.8K shares- - Jan 8, 2025ATYR
aTYR PHARMA INC
Award(A)DirectEmployee Stock Option (right to buy)
275K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 22, 2026 |  TLPH TALPHERA, INC. | Award(A) | 5,100 | - | $0 | Direct |
| Feb 4, 2026 |  ATYR aTYR PHARMA INC | Sale(S) | 1,558 | $0.98 | $1,521 | Direct |
| Feb 3, 2026 | ATYR aTYR PHARMA INC | Exercise(M) | 3,750 | - | $0 | Direct |
| Jan 9, 2026 | ATYR aTYR PHARMA INC | Award(A) Employee Stock Option (right to buy) | 412,500 | - | - | Direct |
| Jan 2, 2026 |  CUE Cue Biopharma, Inc. | Award(A) Stock Option (right to buy) | 24,400 | - | - | Direct |
| Oct 23, 2025 | TLPH TALPHERA, INC. | Award(A) | 4,267 | - | - | Direct |
| Jun 4, 2025 | CUE Cue Biopharma, Inc. | Award(A) Stock Option (right to buy) | 48,800 | - | - | Direct |
| Feb 4, 2025 | ATYR aTYR PHARMA INC | Sale(S) | 1,254 | $3.78 | $4,740 | Direct |
| Feb 3, 2025 | ATYR aTYR PHARMA INC | Exercise(M) | 3,750 | - | - | Direct |
| Jan 8, 2025 | ATYR aTYR PHARMA INC | Award(A) Employee Stock Option (right to buy) | 275,000 | - | - | Direct |
1-10 of 10 transactions
About Broadfoot Jill Marie
Broadfoot Jill Marie (SEC CIK 0001305178) files insider reports with the SEC as Director of TALPHERA, INC. (TLPH), Chief Financial Officer of aTYR PHARMA INC (ATYR) and Director of Cue Biopharma, Inc. (CUE).
Signal8 holds 9 ownership filings by Broadfoot Jill Marie (1 Form 3, 8 Form 4), filed between Jan 10, 2025 and Jun 24, 2026. Those filings report 10 transactions, from Jan 8, 2025 to Jun 22, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Broadfoot Jill Marie's filings is in SAN MATEO, CA.
Recent filings by Broadfoot Jill Marie
- Jun 22, 2026: Grant or award of TLPH shares (Form 4, code A).
- Feb 4, 2026: Open-market sale of ATYR shares (Form 4, code S).
- Feb 3, 2026: Option exercise of ATYR shares (Form 4, code M).
- Jan 9, 2026: Grant or award of ATYR derivative securities (Form 4, code A).
- Jan 2, 2026: Grant or award of CUE derivative securities (Form 4, code A).
Other insiders filing for TALPHERA, INC. (TLPH)
- WAN MARK A, Director
- Todisco Joseph, Director
- JAIN ABHINAV, Director
- HOFFMAN STEPHEN J, Director
- Bozilenko Marina, Director
- ADAMS ADRIAN, Director